from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0960/vapC9

LFCtreatmentdescriptionclass of inhibitor

-1.030

Amikacinug/mL Amikacintranslation

-1.951

Cap5-10ug/mL Capreomycintranslation

-1.727

Rox10-50 ug/mL Roxithromycintranslation

-1.345

SM2-5 ug/mL Streptomycintranslation

-1.846

Tet5-10 ug/mL Tetracyclinetranslation

0.617

Rif0.2-5ug/mL Rifampicintranscription

-0.097

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.076

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.151

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.701

CPZ10-50 ug/mL Chlorpromazinerespiration

1.251

Clofazimine10-13 ug/mL Clofaziminerespiration

0.093

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.975

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.675

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.758

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.001

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.823

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.094

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.847

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.318

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.221

KCN5-20 ug/mL Potassium cyaniderespiration

0.321

NaN30.2-2 mM Sodium aziderespiration

-0.626

Nigericin50 uM Nigericinrespiration

0.160

TRC10-150 ug/mL Triclosanrespiration

1.569

TRZ10-25 ug/mL Thioridazinerespiration

1.789

Valinomycin0.5-10 uM Valinomycinrespiration

-1.598

ZnSO42 mM ZnSO4respiration

1.165

menadione6-10 ug/mL Menadionerespiration

-0.061

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.794

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.862

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.089

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.105

NRP_1Non-replicating persistence stage 1dosRassociated

-0.724

Amp0.2mg/mL AmpicillincellWall

-0.490

Cephalexin20-100 ug/mL CephalexincellWall

-1.151

Cerulenin0.32-5 ug/mL CerulenincellWall

0.016

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.425

EMB10-20 ug/mL EthambutolcellWall

-0.949

Eta12-40 ug/mL EthionamidecellWall

-1.219

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.413

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.002

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.432

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.043

BZA0.12 mg/mL BenzamidearomaticAmides

0.137

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.512

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.225

H2O24 mM hydrogen peroxideDNAdamaging

-0.461

Levo10 ug/mL LevofloxacinDNAdamaging

-0.043

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.431

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.542

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.359

UVUV-irradiationDNAdamaging

1.549

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.851

Antimycin12.5-50 ug/mL Antimycin A?

0.526

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.268

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.674

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.625

PA8240.2-2 ug/mL PA-824?

-0.329

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.041

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.338

Verapamil50 uM Verapamil?

0.764

mercaptoethanol2 mM 2-Mercaptoethanol?

0.354

methoxatin10-20 ug/mL Methoxatin?